Novel biomarkers for risk stratification in pulmonary arterial hypertension
Risk stratification in pulmonary arterial hypertension (PAH) is paramount to identifying individuals at highest risk of death. So far, there are only limited parameters for prognostication in patients with PAH.
Main Authors: | , , , , , , , |
---|---|
Format: | Online |
Language: | English |
Published: |
European Respiratory Society
2015
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5005111/ |